Drug-eluting fully covered self-expanding metal stent for dissolution of bile duct stones in vitro

Table 2 Serology of experimental animals before and after stent placement (mean ± SD)

	Naked FCSEMS (n = 6)			Stent III (n = 6)
	Day 0	Day 15	Day 30	Day 0	Day 15	Day 30
ALT (U/L)	33.06 ± 7.31	29.93 ± 8.22	32.10 ± 5.97	33.16 ± 6.14	30.50 ± 3.41	35.66 ± 5.51
AST (U/L)	29.60 ± 3.82	34.86 ± 7.28	34.66 ± 8.73	48.64 ± 18.81	28.06 ± 4.00	29.37 ± 3.33
Alb (g/L)	30.80 ± 5.33	31.50 ± 6.07	32.56 ± 5.43	32.44 ± 5.37	34.6 ± 0.81	34.54 ± 6.26
TBIL (umol/L)	1.32 ± 0.38	1.95 ± 0.54	1.80 ± 0.37	1.68 ± 0.26	2.14 ± 0.65	1.74 ± 0.55
TBA (umol/L)	16.43 ± 7.24	16.83 ± 9.50	13.30 ± 3.55	16.56 ± 8.58	9.21 ± 1.90	16.90 ± 9.35
γ-GT (U/L)	44.04 ± 9.29	41.36 ± 3.59	42.62 ± 7.18	47.40 ± 7.60	42.38 ± 3.74	41.16 ± 9.57
ALP (U/L)	167.02 ± 42.32	138.33 ± 47.60	144.12 ± 40.23	158.4 ± 60.56	124.20 ± 31.39	163.00 ± 28.91
Cre (umol/L)	47.90 ± 12.16	46.06 ± 9.27	48.00 ± 13.94	39.12 ± 12.96	49.72 ± 10.50	60.02 ± 19.71
Ca (mmol/L)	2.89 ± 0.28	2.57 ± 0.01	2.86 ± 0.33	2.60 ± 0.52	2.75 ± 0.53	2.81 ± 0.29
Mg (mmol/L)	1.01 ± 0.08	0.93 ± 0.06	1.14 ± 0.27	1.28 ± 0.21	1.00 ± 0.22	1.04 ± 0.25

FCSEMS: Fully covered self-expanding metal stent; ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; TBIL: Total bilirubin; TBA: Total bile acids; γ-GT: γ-glutamine transaminase; Alb: Albumin; ALP: Alkaline phosphatase; Cre: Creatinine.